Solving some of the world’s greatest challenges requires a disruptive way of thinking and novel technologies. Both cutting edge research in the academic environment and R&D efforts in the private sector aim to achieve these goals. Finding innovative solutions through interdisciplinary collaboration is a central goal at the GapSummit 2018. We will explore emerging and future trends across all biotech sectors. A diverse group of experts will discuss current efforts to drive technological advances in fields, such as healthcare, clean-tech and agri-tech.




Future of Healthcare and Personalized Medicine

The healthcare sector increasingly recognises the advent of personalised medicine. In particular, novel technologies to advance digital healthcare have created new avenues to monitor individual patients and to identify early symptoms of human diseases. It is thus no surprise that established tech companies including Google and Apple are currently expanding their focus on healthcare and biotech. Pioneering individuals and companies will outline and discuss their vision of personalised medicine and how it will revolutionise healthcare.





Food and energy supply for a growing population and climate change are key issues to be resolved in the very near future. Novel technologies and biotech ventures are a prerequisite to achieve global sustainability. We will focus on advances in agricultural biotechnology, particularly in developing countries, and how genetically modified crops are contributing to the advent of the second green revolution. Over the past years, gene editing has also been applied to improve yields of food supply other than crops. Besides the food industry, numerous biotech ventures are developing innovative solutions to develop biofuels and alternative energy sources to address the global energy crisis. What role can biotechnology play in the attempt to solve these worldwide challenges?



Policy-making in Pharma and Biotech

Drug pricing is a common debate in the pharmaceutical and biotech industry and has certainly contributed to the negative reputation of Big Pharma companies. During the GapSummit 2018, we will host a debate with experts from regulatory bodies, insurance organisations, large pharmaceutical companies, and small biotech ventures. The aim of this debate will be to discuss the process of global drug pricing and the justification of treatment costs. Policy-makers hold a major responsibility in the pharmaceutical industry and thus their decision-making is critical for this industry.




Accessing Global Markets

Differences in region, culture, and regulation drive variability in the biotech sector across the globe. Hence, breaking into new markets remains a challenge, even for multi-national corporations. We believe disruptive thinking and innovative ideas of young entrepreneurs need to be shared globally. However, inexperience and financial risk often form significant barriers, preventing the expansion of young start-ups. At the GapSummit 2018, we aim to provide an insight into the intricate differences between key global biotechnology markets, prepare young leaders for the challenges and help overcome these barriers. A panel of current leaders from different regions will compare and contrast the biotech industry across the continents.  



Road from Academia to Industry

Many young bio-entrepreneurs have a strong academic research background. Often, these experiences heavily influence the identification of a gap in the market and the subsequent development of a new technology. However, realising the commercial potential of new discoveries provides a very different challenge to the scientific development. How would you drive the commercialisation of a novel application or technology that was born in an academic laboratory? Research pioneers and serial entrepreneurs will give an insight into their experiences and provide advice on the first steps towards your start-up.





This Gap will focus on two aspects: funding opportunities for young biotech entrepreneurs as well as trends in biotech investment. As a young entrepreneur, raising funding throughout the early stages of the venture is a crucial yet daunting task. We will discuss sources of funding in the biotech industry and beyond. Funding experts will include angel investors, venture capitalists and corporate investors. Besides funding opportunities for young start-ups, the discussion will focus on current and future trends in biotech investments.